Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256725335> ?p ?o ?g. }
- W4256725335 endingPage "225" @default.
- W4256725335 startingPage "218" @default.
- W4256725335 abstract "Abstract Clinical outcomes for children with acute myeloid leukemia (AML) have improved minimally during the past 4 decades despite maximally intensive chemotherapy, hematopoietic stem cell transplantation, and optimized supportive care. Chemoresistance and relapse remain major sources of childhood cancer–associated mortality and highlight the need for alternative treatment approaches. The remarkable recent success of humoral and cellular immunotherapies in children and adults with relapsed/refractory B-acute lymphoblastic leukemia has inspired hope for similar accomplishments in patients with AML. However, unique challenges exist, including the biologic and immunophenotypic heterogeneity of childhood AML and the significant potential for on-target/off-tumor immunotherapeutic toxicity due to target antigen expression on nonmalignant cells. This article reviews the current landscape of antibody-based and cellular immunotherapies under current clinical evaluation with an emphasis on active or soon-to-open phase 1 trials for children with relapsed/refractory AML." @default.
- W4256725335 created "2022-05-12" @default.
- W4256725335 creator A5043814334 @default.
- W4256725335 creator A5066964026 @default.
- W4256725335 date "2019-12-06" @default.
- W4256725335 modified "2023-09-26" @default.
- W4256725335 title "Opportunities for immunotherapy in childhood acute myeloid leukemia" @default.
- W4256725335 cites W1619537825 @default.
- W4256725335 cites W1979544480 @default.
- W4256725335 cites W2030249962 @default.
- W4256725335 cites W2046733598 @default.
- W4256725335 cites W2052690356 @default.
- W4256725335 cites W2077031414 @default.
- W4256725335 cites W2077994554 @default.
- W4256725335 cites W2095288229 @default.
- W4256725335 cites W2098476581 @default.
- W4256725335 cites W2102304044 @default.
- W4256725335 cites W2112362958 @default.
- W4256725335 cites W2121565126 @default.
- W4256725335 cites W2132693111 @default.
- W4256725335 cites W2169923083 @default.
- W4256725335 cites W2284799323 @default.
- W4256725335 cites W2344819251 @default.
- W4256725335 cites W2396687607 @default.
- W4256725335 cites W2417767096 @default.
- W4256725335 cites W2521461373 @default.
- W4256725335 cites W2529226476 @default.
- W4256725335 cites W2529540084 @default.
- W4256725335 cites W2585315580 @default.
- W4256725335 cites W2593086395 @default.
- W4256725335 cites W2607531045 @default.
- W4256725335 cites W2614562262 @default.
- W4256725335 cites W2659232377 @default.
- W4256725335 cites W2726931548 @default.
- W4256725335 cites W2751476275 @default.
- W4256725335 cites W2761903029 @default.
- W4256725335 cites W2766163135 @default.
- W4256725335 cites W2768799228 @default.
- W4256725335 cites W2773514102 @default.
- W4256725335 cites W2774586064 @default.
- W4256725335 cites W2787145330 @default.
- W4256725335 cites W2793137791 @default.
- W4256725335 cites W2793614832 @default.
- W4256725335 cites W2794863799 @default.
- W4256725335 cites W2800912743 @default.
- W4256725335 cites W2804727484 @default.
- W4256725335 cites W2807706866 @default.
- W4256725335 cites W2880011386 @default.
- W4256725335 cites W2898640974 @default.
- W4256725335 cites W2898689626 @default.
- W4256725335 cites W2899502645 @default.
- W4256725335 cites W2903930842 @default.
- W4256725335 cites W2913271650 @default.
- W4256725335 cites W2947731597 @default.
- W4256725335 cites W2947795161 @default.
- W4256725335 cites W2952354682 @default.
- W4256725335 cites W2964884228 @default.
- W4256725335 doi "https://doi.org/10.1182/hematology.2019000357" @default.
- W4256725335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31808843" @default.
- W4256725335 hasPublicationYear "2019" @default.
- W4256725335 type Work @default.
- W4256725335 citedByCount "1" @default.
- W4256725335 countsByYear W42567253352022 @default.
- W4256725335 crossrefType "journal-article" @default.
- W4256725335 hasAuthorship W4256725335A5043814334 @default.
- W4256725335 hasAuthorship W4256725335A5066964026 @default.
- W4256725335 hasBestOaLocation W42567253351 @default.
- W4256725335 hasConcept C121608353 @default.
- W4256725335 hasConcept C126322002 @default.
- W4256725335 hasConcept C142424586 @default.
- W4256725335 hasConcept C143998085 @default.
- W4256725335 hasConcept C203014093 @default.
- W4256725335 hasConcept C2776694085 @default.
- W4256725335 hasConcept C2777408962 @default.
- W4256725335 hasConcept C2777701055 @default.
- W4256725335 hasConcept C2778729363 @default.
- W4256725335 hasConcept C2779282312 @default.
- W4256725335 hasConcept C2911091166 @default.
- W4256725335 hasConcept C535046627 @default.
- W4256725335 hasConcept C71924100 @default.
- W4256725335 hasConcept C86803240 @default.
- W4256725335 hasConcept C87355193 @default.
- W4256725335 hasConceptScore W4256725335C121608353 @default.
- W4256725335 hasConceptScore W4256725335C126322002 @default.
- W4256725335 hasConceptScore W4256725335C142424586 @default.
- W4256725335 hasConceptScore W4256725335C143998085 @default.
- W4256725335 hasConceptScore W4256725335C203014093 @default.
- W4256725335 hasConceptScore W4256725335C2776694085 @default.
- W4256725335 hasConceptScore W4256725335C2777408962 @default.
- W4256725335 hasConceptScore W4256725335C2777701055 @default.
- W4256725335 hasConceptScore W4256725335C2778729363 @default.
- W4256725335 hasConceptScore W4256725335C2779282312 @default.
- W4256725335 hasConceptScore W4256725335C2911091166 @default.
- W4256725335 hasConceptScore W4256725335C535046627 @default.
- W4256725335 hasConceptScore W4256725335C71924100 @default.
- W4256725335 hasConceptScore W4256725335C86803240 @default.
- W4256725335 hasConceptScore W4256725335C87355193 @default.
- W4256725335 hasIssue "1" @default.